Dis-Chem PharmaciesJSE:DCP +0.34%85 PE Ratio (TTM) is 28.60 as of Jul. 12, 2026, which is 9% below its 10-year median of 31.27. GuruFocus rates JSE:DCP with a GF Score™ of 85/100 and a GF Value™ of R38.17 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 432 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks worse than 61.81% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-12), Dis-Chem Pharmacies's share price is
R32.60.
Dis-Chem Pharmacies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was R1.14. Therefore, Dis-Chem Pharmacies's PE Ratio (TTM) for today is 28.60.
The historical rank and industry rank for Dis-Chem Pharmacies's PE Ratio (TTM) or its related term are showing as below:
JSE:DCP'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 19.35 Med: 31.27 Max: 62.84
Current: 28.6
During the past 13 years, the highest PE Ratio (TTM) of Dis-Chem Pharmacies was 62.84. The lowest was 19.35. And the median was 31.27.
JSE:DCP's PE Ratio (TTM) is ranked worse than 61.81% of 432
companies
in the Healthcare Providers & Services industry
Industry Median: 22.285
vs JSE:DCP: 28.60
During the past 12 months, Dis-Chem Pharmacies's average EPS without NRIGrowth Rate was -17.30% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -0.80% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 8.50% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 1.70% per year.
During the past 13 years, Dis-Chem Pharmacies's highest 3-Year average EPS without NRI Growth Rate was 18.70% per year. The lowest was -33.10% per year. And the median was -0.30% per year.
Dis-Chem Pharmacies's EPS (Basic) for the
six
months ended in Feb. 2026 was R0.40.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 was R1.14.
Dis-Chem Pharmacies (JSE:DCP) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Dis-Chem Pharmacies PE Ratio (TTM) Related Terms
Dis-Chem Pharmacies PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies PE Ratio (TTM) Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies PE Ratio (TTM) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Dis-Chem Pharmacies's Share Price of today is R32.60.
For company reported semi-annually, Dis-Chem Pharmacies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R1.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Dis-Chem Pharmacies (JSE:DCP) has a PE Ratio (TTM) of 28.60 as of Jul. 12, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Dis-Chem Pharmacies and its competitors. This is near median its historical median of 31.27. Over the past decade, Dis-Chem Pharmacies' PE Ratio (TTM) has ranged from 19.35 to 62.84. According to the industry distribution chart, Dis-Chem Pharmacies ranks #267 out of 432 companies in the Healthcare Providers & Services industry, placing it in the top 61.8%.
Is Dis-Chem Pharmacies' PE Ratio (TTM) too high?
Dis-Chem Pharmacies' current PE Ratio (TTM) of 28.60 is near median its 10-year median of 31.27. Over the past 10 years, this metric has ranged from a low of 19.35 to a high of 62.84. The Healthcare Providers & Services industry median PE Ratio (TTM) is 22.29. Dis-Chem Pharmacies' value of 28.60 is 28.3% above this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #267 out of 432 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' PE Ratio (TTM) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #267 out of 432 companies for PE Ratio (TTM). This places Dis-Chem Pharmacies in the lower half of its industry. The industry median PE Ratio (TTM) is 22.29. Dis-Chem Pharmacies' value of 28.60 is 28.3% above this benchmark. Historically, Dis-Chem Pharmacies' own PE Ratio (TTM) has ranged from 19.35 to 62.84 over the past decade. While the company's 10-year median is 31.27 vs. the industry median of 22.29, Dis-Chem Pharmacies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Healthcare Providers & Services company?
The median PE Ratio (TTM) among Healthcare Providers & Services companies is 22.29, based on 432 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current PE Ratio (TTM) of 28.60 is 28.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio (TTM) is 22.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current PE Ratio (TTM) is 28.60, which is near median its own 10-year median of 31.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.17, compared to a current price of R32.60 — trading 14.6% below its estimated fair value. The current PE Ratio (TTM) is 28.60, which is near median its 10-year median of 31.27 and 28.3% above the Healthcare Providers & Services industry median of 22.29. Dis-Chem Pharmacies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current PE Ratio (TTM) is 28.60 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R32.60 is trading 14.6% below its estimated GF Value™ of R38.17.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
PE Ratio (TTM): 28.60 (near median its 10-year median of 31.27)
GF Value™: R38.17 vs. price of R32.60 (14.6% below fair value)
Industry Position: 28.3% above the Healthcare Providers & Services median (#267 of 432)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
85GF Score
Get the complete analysis for JSE:DCP
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
